Company & Sponsor Intelligence

JPM van Stralen Medicine Professional

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed2

Countries1

Therapeutic footprint

adhdautism

Indexed studies

NCT01985581Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD
adhd · CanadaPHASE4

NCT04741516Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD
adhd · CanadaPHASE4

NCT03337646Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
autism · CanadaPHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →